CA
MRTX

Crewe Advisors’s Mirati Therapeutics, Inc. Common Stock MRTX Stock Holding History

Crewe Advisors’s Portfolio MRTX Stock Details MRTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change % 		Capital Flow Portfolio Weight Portfolio Position
2023
Q2 		– Sell
-33
Closed -$1.23K – 1028
2023
Q1 		$1.23K Hold
33
– – ﹤0.01% 743
2022
Q4 		$1.5K Sell
33
-34
-51% -$1.54K ﹤0.01% 878
2022
Q3 		$5K Buy
67
+20
+43% +$1.49K ﹤0.01% 867
2022
Q2 		$3K Buy
+47
New +$3K ﹤0.01% 943